Loading SHIVALIK price...
Peers are the listed companies in the exchange's own industry group: Pesticides & Agrochemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales rose 7.9% from a year earlier to Rs 96.3 cr and profit rose 59.5% to Rs 4.5 cr.
- Sales grew 3 years running (Rs 234 cr in FY23 to Rs 368 cr in FY26).
- Operating margin fell from 18.3% in FY23 to 12.4% in FY26.
- Return on equity stayed under 10% from FY24 to FY26 (highest 3.8%).
- Operations used cash in FY26 (-Rs 34.0 cr) while reported profit was Rs 18.0 cr.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 19 results, the share rose on 5 and fell on 14, and moved by 3% or more on 13.
Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -2.17%.
Of every Rs 100 of sales in FY26, Rs 88 went on running costs, Rs 5.1 on depreciation, Rs 2.6 on interest and Rs 1.0 on tax; Rs 4.9 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | 16.5% | 14.2% | 18.0% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | 18.3% | 14.4% | 12.9% | 12.4% |
| Net marginProfit after everything, per Rs 100 of sales. | 12.7% | 6.6% | 6.5% | 4.9% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | 7.1% | 3.6% | 3.8% | 3.0% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 8.3% | 5.8% | 5.9% | 4.9% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.14x | 0.15x | 0.18x | 0.19x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | 8.4x | 4.1x | 3.5x | 3.2x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 819 Cr of assets. Its owners funded 73% of that and borrowings 14%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -34 Cr, spent Rs 23 Cr on plant and equipment, and cash rose by Rs 6 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| UPL UPL Limited | 42,056 cr | 20.6x | 1.2x | 5.6% | 11.2% | 0.53 | 4.4% | +10.5% | 1.16% |
| PIIND PI Industries Limited | 30,704 cr | 26.3x | 2.7x | 10.4% | 14.6% | 0.02 | 17.9% | -10.4% | 0.74% |
| SUMICHEM Sumitomo Chemical India Limited | 17,685 cr | 61.2x | 5.2x | 17.1% | 21.0% | 0.00 | 17.9% | +0.6% | 0.34% |
| SHARDACROP Sharda Cropchem Limited | 5,688 cr | 9.1x | 1.8x | 20.0% | 25.3% | 0.00 | 11.7% | +9.0% | 1.91% |
| DHANUKA Dhanuka Agritech Limited | 3,709 cr | 14.0x | 2.2x | 15.9% | 22.1% | 0.00 | 13.7% | -12.6% | 0.24% |
| RALLIS Rallis India Limited | 3,664 cr | 17.6x | 1.8x | 10.5% | 12.3% | 0.00 | 7.2% | +6.8% | 1.34% |
| NACLIND NACL Industries Limited | 2,650 cr | 221.8x | 3.9x | 1.8% | 7.8% | 0.44 | 0.8% | -14.5% | 0.00% |
| BHAGCHEM Bhagiradha Chemicals & Industries Limited | 2,512 cr | 91.4x | 3.6x | 3.9% | 4.4% | 0.33 | 4.5% | +57.6% | 0.08% |
| GSPCROP GSP Crop Science Limited | 2,010 cr | - | 2.6x | - | 20.2% | 0.34 | - | - | 0.15% |
| INSECTICID Insecticides (India) Limited | 1,522 cr | 12.2x | 1.3x | 10.3% | 16.1% | 0.12 | 6.1% | -11.5% | 0.38% |
| ASTEC Astec LifeSciences Limited | 1,455 cr | - | 3.7x | -17.0% | -10.5% | 1.15 | -15.1% | -8.3% | 0.00% |
| MOL Meghmani Organics Limited | 1,397 cr | 21.7x | 0.9x | 4.2% | 8.6% | 0.47 | 3.0% | -11.5% | 0.00% |
| IPL India Pesticides Limited | 1,314 cr | 12.2x | 1.3x | 10.7% | 16.2% | 0.11 | 10.4% | -8.5% | 0.66% |
| PUNJABCHEM Punjab Chemicals & Crop Protection Limited | 1,196 cr | 18.3x | 2.8x | 15.4% | 20.7% | 0.36 | 6.2% | +8.7% | 0.31% |
| ADVANCE Advance Agrolife Limited | 845 cr | 15.4x | 2.7x | 15.8% | 17.2% | 0.31 | 6.1% | +96.0% | 0.00% |
| DHARMAJ Dharmaj Crop Guard Limited | 811 cr | 13.5x | 1.8x | 13.4% | 17.6% | 0.29 | 5.2% | +4.1% | 0.00% |
| HERANBA Heranba Industries Limited | 585 cr | - | 0.8x | -10.0% | -2.4% | 0.74 | -5.0% | -15.3% | 0.68% |
| SHIVALIK Shivalik Rasayan Limited | 494 cr | 36.2x | 0.8x | 3.3% | 4.9% | 0.19 | 5.2% | +7.9% | 0.43% |
| BHARATRAS Bharat Rasayan Limited | 388 cr | 6.8x | 0.3x | 11.0% | 15.1% | 0.00 | 11.6% | -10.4% | 0.16% |
| IGCL Indogulf Cropsciences Limited | 361 cr | 11.0x | 0.8x | 8.4% | 14.7% | 0.39 | 5.6% | -11.0% | 0.00% |
| BESTAGRO Best Agrolife Limited | 32 cr | 0.8x | 0.0x | 3.9% | 7.6% | 0.56 | 2.3% | +3.9% | 21.99% |
| SIKKO Sikko Industries Limited | 10 cr | 3.5x | 0.1x | 7.1% | 8.1% | 0.14 | 9.4% | -2.3% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 18.3% to 12.4% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.